New SERMs in development.
Neven
P
P
Department of Gynecologic Oncology & Multidisciplinary Breast Unit, University Hospitals KULeuven, Belgium, Herestraat 49, Leuven, Belgium. patrick.neven@uz.kuleuven.ac.be
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D051381:Rats; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy*
D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen